Your session is about to expire
← Back to Search
Case management for Opioid Use Disorder (ConNECT Trial)
N/A
Waitlist Available
Led By Alia Al-Tayyib, PhD
Research Sponsored by Denver Health and Hospital Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days from treatment initiation
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing an intervention to help people with opioid addiction stay in treatment at Denver Health.
Eligible Conditions
- Opioid Use Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days from treatment initiation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days from treatment initiation
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Retention in treatment at 90 days
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
dedicated case management
Group II: Usual careActive Control1 Intervention
usual care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Case management
2014
Completed Phase 3
~2990
Find a Location
Who is running the clinical trial?
Denver Health and Hospital AuthorityLead Sponsor
104 Previous Clinical Trials
402,018 Total Patients Enrolled
Centers for Disease Control and PreventionFED
887 Previous Clinical Trials
21,993,355 Total Patients Enrolled
Alia Al-Tayyib, PhDPrincipal Investigator - Denver Health
Denver Health and Hospital Authority
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Usual care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger